Research and Markets (http://www.researchandmarkets.com/research/hclqqj/plague_pipeline) has announced the addition of the "Plague - Pipeline Review, H2 2013" report to their offering.

"Plague - Pipeline Review, H2 2013" provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Plague, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Plague.

Scope

  • A snapshot of the global therapeutic scenario for Plague.
  • A review of the Plague products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
  • Coverage of products based on various stages of development ranging from discovery till registration stages.
  • A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
  • Coverage of the Plague pipeline on the basis of route of administration and molecule type.
  • Key discontinued pipeline projects.
  • Latest news and deals relating to the products.

Plague - Companies Involved in Therapeutics Development

  • Takeda Pharmaceutical Company Limited
  • Summit Corporation plc
  • Mucosis B.V.
  • iBio, Inc.
  • Cellceutix Corporation

Drug Profiles

  • rF1V Vaccine
  • Flagellin/F1/V Vaccine
  • PMX-30016
  • SMT-15000
  • Subunit Vaccine For Plague
  • Plague Vaccine
  • Yersinia Pestis Vaccine
  • Subunit Vaccine For Anthrax-Plague Combination
  • Yersinia Pestis Vaccine
  • Yersinia Pestis Vaccine
  • tPA-V DNA Vaccine
  • Small Molecule to Inhibit YoPH for Plague

For more information visit http://www.researchandmarkets.com/research/hclqqj/plague_pipeline.

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Infectious Diseases